Case studies of spinal cord injury patients treated with CD34+ and mesenchymal stem cells harvested from human umbilical cord Wharton's jelly and cord blood, animal studies using mesenchymal stem cells, immunosuppression requirements in allogeneic stem cell treatments, intrathecal and intravenous administration of autologous bone marrow stem cells in spinal cord injury patients, and the role [...]
Part 1: Dr. Riordan discusses mesenchymal stem cell sources from umbilical cord Wharton's jelly, stem cell expansion, therapeutic potential of umbilical cord mesenchymal stem cells vs. bone marrow mesenchymal stem cells, CD34+ hematopoietic stem cells from umbilical cord blood and the scientific rationale supporting stem cell treatment of spinal cord injury.
Dr. Riordan discusses focuses on mesenchymal stem cells harvested from fat tissue and the role they play in reducing inflammation, repairing tissue and modulating the immune system.
Neil Riordan PhD presents the scientific rationale for using adipose tissue-derived stem cells and T-regulatory cells to treat MS and rheumatoid arthritis. Dr. Riordan is the Founder and President of the Stem Cell Institute in Panama City, Panama.
Dr. Neil Riordan presents data on human umbilical cord-derived stem cell treatments. Dr. Riordan is Founder of the Stem Cell Institute in Panama City, Panama.
Dr. Riordan discussed types of stem cells used in treatments with a focus on adipose and umbilical cord derived stem cells, including their roles in immune system modulation, inflammation reduction and tissue repair:Autoimmune diseases and spinal cord Injury are highlighted. Dr. Riordan is the Founder of the Stem Cell Institute in Panama City, Panama.